STEPHANIE CORMAN: Open Payments
NPI 1659824175 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,303 in 53 payments from 20 companies in 2025. Trend: 2023 $876 · 2024 $773 · 2025 $1,303
Food & beverage: $1,303
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 11 | $319 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $158 |
| Medtronic, Inc. | 6 | $109 |
| Novartis Pharmaceuticals Corporation | 3 | $99 |
| ABBVIE INC. | 5 | $95 |
| Janssen Biotech, Inc. | 5 | $83 |
| Boston Scientific Corporation | 1 | $81 |
| Dendreon Pharmaceuticals LLC | 2 | $78 |
| Calyxo, Inc. | 3 | $61 |
| IMMUNITYBIO, INC. | 2 | $29 |
Products named: GEMTESA, Nubeqa, PLUVICTO, BOTOX, ERLEADA, AMS 700, PROVENGE, CVAC ASPIRATION SYSTEM.
Industry payments across IN — which companies pay providers there.
